Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372475 · ClinicalTrials.gov registry record · Phase 3
Hymovis™ Versus Placebo in Knee Osteoarthritis
A Phase 3 study, sponsored by Fidia Farmaceutici s.p.a..
- Completed
- Registry status
- Phase 3
- Development phase
- 800
- Enrollment target
NCT01372475: Completed Phase 3 study, sponsored by Fidia Farmaceutici s.p.a..
NCT01372475 is a Phase 3 study that has completed, run by Fidia Farmaceutici s.p.a.. The registered enrollment target is 800 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372475, a Phase 3 study, has completed, sponsored by Fidia Farmaceutici s.p.a..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 800 participants
- Enrollment target
Study Summary
Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.
Primary Outcome
WOMAC A Pain sub-score
Interventions
- DEVICE Hymovis Intra-articular Injection
- PROCEDURE Phosphate Buffered Saline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
What the finished NCT01372475 record still lists
NCT01372475 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Hymovis Intra-articular Injection is the first listed.
NCT01372475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01372475 about?
NCT01372475 is a clinical study titled "Hymovis™ Versus Placebo in Knee Osteoarthritis". Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.
What is the current status of trial NCT01372475?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 800 participants. The study started on 2011-03. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01372475?
The interventions under investigation include: Hymovis Intra-articular Injection (DEVICE), Phosphate Buffered Saline Injection (PROCEDURE).
Who is sponsoring clinical trial NCT01372475?
This trial is sponsored by Fidia Farmaceutici s.p.a., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01372475's enrollment target sits among peer trials
800 414th of 2000 higher than 1,573 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia